1. Home
  2. EQH vs KTTA Comparison

EQH vs KTTA Comparison

Compare EQH & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Equitable Holdings Inc.

EQH

Equitable Holdings Inc.

HOLD

Current Price

$52.43

Market Cap

13.3B

Sector

Finance

ML Signal

HOLD

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$0.51

Market Cap

18.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EQH
KTTA
Founded
1859
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.3B
18.1M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
EQH
KTTA
Price
$52.43
$0.51
Analyst Decision
Buy
Strong Buy
Analyst Count
11
1
Target Price
$56.82
$3.00
AVG Volume (30 Days)
2.5M
221.9K
Earning Date
05-04-2026
05-14-2026
Dividend Yield
2.60%
N/A
EPS Growth
N/A
77.07
EPS
0.50
N/A
Revenue
$11,665,000,000.00
$486,559.00
Revenue This Year
$43.13
N/A
Revenue Next Year
$7.45
N/A
P/E Ratio
$107.74
N/A
Revenue Growth
N/A
3130.37
52 Week Low
$35.20
$0.28
52 Week High
$55.06
$2.06

Technical Indicators

Market Signals
Indicator
EQH
KTTA
Relative Strength Index (RSI) 62.40 46.43
Support Level $47.10 $0.48
Resistance Level N/A $0.52
Average True Range (ATR) 1.16 0.04
MACD 0.07 -0.01
Stochastic Oscillator 73.99 28.89

Price Performance

Historical Comparison
EQH
KTTA

About EQH Equitable Holdings Inc.

Equitable Holdings Inc is a financial services company providing retirement, asset management, and wealth management solutions for individual and institutional clients, operating through three segments. The Retirement segment generates the majority of revenue and offers annuities, retirement savings plans, institutional savings products, and includes the spread lending business. The Asset Management segment provides diversified investment management and related services globally through Institutional, Retail, and Private Wealth channels and reflects the business of AB. The Wealth Management segment offers advisory accounts, financial planning and advice, life insurance, and annuity products. Revenues are earned predominantly from fee income, income from investments, and insurance premiums.

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

Share on Social Networks: